INMB INmune Bio Corporation: Uzoq muddatli qarzning kapitalga koeffitsiyenti
INmune Bio, Inc. (INMB) saraton bilan kurashish uchun ilg'or immunologlardan foydalanish strategiyasi kompaniyaning uzoq muddatli qarzning kapitalga nisbati dinamikasini belgiladi va ushbu ko'rsatkich 0.03 darajasida turibdi. Biologik yo'nalish patentlari raqobatchilarga qarshi himoya to'sig'ini yaratgan bo'lsa-da, onkologiya va Altsgeymer terapiyasi bo'yicha erta bosqichdagi ishlanmalarning yuqori konsentratsiyasi joriy savdoning yo'qligi sababli moliyaviy xatarlarni oshiradi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_INMB_-_INmune-Bio-Inc._-_Long-Term-Debt-to-Capital "INMB: INmune Bio Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
INmune Bio, Inc. (INMB) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati INmune Bio, Inc.|INMB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati inmunebio.com|INMB - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati INmune Bio, Inc.|INMB - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi INmune Bio
Kompaniyaning dastlabki tahlili:INMB, INmune Bio Inc
Ushbu ko'rsatkich kompaniyaning uzoq muddatli qarzlarining uning own kapitaliga nisbatan bog'liqligini belgilaydi. Kapital tuzilmasidagi uzoq muddatli kreditlarning ulushini tahlil qilish orqali investorlar foiz stavkalari o'zgarishi bilan bog'liq qarz yuklamasi xavfini baholaydilar. Mazkur ko'rsatkich agressiv moliyalashtirish va moliyaviy barqarorlik o'rtasidagi muvozanatni ochib beradi. INmune Bio, Inc. (INMB) uchun bu juda muhimdir, chunki sintezni avtomatlashtirish qimmatbaho, ko'p yillik klinik sinovlarning zarurligini bartaraf etmaydi. Bu yerda yuqori kredit yuki dori vositalarini ishlab chiqishni tezlashtirish vositasi bo'lib xizmat qilishi mumkin.
Toʻgʻridan-toʻgʻri raqobatchilar
Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati argenx N.V.|BioNTech Group (BNTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Abivax S.A. (ABVX)|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|protagonist-inc.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunovant (IMVT)|KNSA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|GRFS (Grifols Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adaptive Biotechnologies Inc. (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Vera Therapeutics Inc (VERA)|Uzoq muddatli qarzning kapitalga nisbati DNTH|Pharvaris Pharma - Uzoq muddatli qarzdorlikning kapitalga nisbati|ABCL: Uzoq muddatli qarzning o'z kapitaliga nisbati|TRML: Uzoq muddatli qarzning o'z kapitaliga nisbati|PGEN (Precigen) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|NKTR (Nektar) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati UPB|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc ZBIO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi immunome.com (IMNM)|GOSS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati KalVista Pharma KALV|Uzoq muddatli qarzning kapitalga nisbati SEPN (Septerna Corp)|PVLA: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Savara Inc.|RIGL (rigel.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati ANAB|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics Inc (ATXS)|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN|Uzoq muddatli qarzning kapitalga nisbati RAPT (rapt.com)|JBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi aclaristx.com ACRS|KYTX (Kyverna Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Tiziana Life Sciences Ltd. (TLSA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cabaletta Bio, Inc CABA|Ventyx Biosciences, Inc (VTYX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati Theratechnologies Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati avalotx.com|ELDN (Eledon Pharmaceuticals, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati AGEN (Agenus, Inc.)|CLYM: Uzoq muddatli qarzning o'z kapitaliga nisbati|ZURA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati aTyr Pharma, Inc. (ATYR)|ADAG - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ikenaoncology.com - Uzoq muddatli qarzning kapitalga nisbati|STTK (Shattuck Labs) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium Inc (EQ)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Connect Pharma|Uzoq muddatli qarzning kapitalga nisbati IMUX (Immunic, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati atarabio.com ATRA|Uzoq muddatli qarzning o'z kapitaliga nisbati IFRX|Uzoq muddatli qarzdorlikning kapitalga nisbati X4 Pharmaceuticals Inc. XFOR|Uzoq muddatli qarzning kapitalga nisbati ACET (Adicet)|CELU: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Barinthus Biotherapeutics|KZR (kezarlifesciences.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|Uzoq muddatli qarzning o'z kapitaliga nisbati Akari Therapeutics PLC|Uzoq muddatli qarzning kapitalga nisbati Enlivex Therapeutics (ENLV)|Uzoq muddatli qarzning o'z kapitaliga nisbati QTTB (q32bio.com)|GeoVax Labs, Inc. (GOVX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati edesabiotech.com EDSA|Uzoq muddatli qarzning kapitalga nisbati iBio (IBIO)|CARM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|XTLB: Uzoq muddatli qarzning kapitalga nisbati|BOLT (Bolt Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|HCWB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti APVO|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|Uzoq muddatli qarzning o'z kapitaliga nisbati aditxt.com (ADTX)|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|XRTX - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vyome Holdings Inc (HIND)|REVB - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Indaptus Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|SCNI (Scinai Immunotherapeutics Ltd) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CALI|Uzoq muddatli qarzning o'z kapitaliga nisbati AFMD|Uzoq muddatli qarzning o'z kapitaliga nisbati ALLK (Allakos Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning o'z kapitaliga nisbati IGMS (IGM Biosciences)|iTeos Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati|Ocean Bio (OCEA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|TCBP - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati THRD